Pharmaceuticals

Eli Lilly’s Chief Financial Officer Steps Down

bexib
By bexib 0 Min Read

Anat Ashkenazi will be leaving the company at the end of July to pursue a career outside the pharmaceutical industry.

You Might Also Like

APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology

Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins

New ways to determine drug value with health equity in mind

Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions

Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer

Share This Article
Previous Article Sole Proprietorship vs. LLC (2024)
Next Article CROSSROADS Maldives appoints Ibrahim Farhad as Director of Retail – Hotel Rie Maldives
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

India’s digital banking revolution driven by innovation, regulatory support and advanced digital infrastructure
Fintech
Café Boulud opens at Four Seasons Hotel Riyadh, offering an elevated French culinary experience
Hospitality & Tourism
Open Source Hardware Certification for August 2024
Manufacturing
Scotia considers Google Cloud for cybersecurity solution
Banking